Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boehringer ingelheim
clinical trials
eli lilly
empagliflozin
europe
europe blog main
europe top stories
fda
indiana blog main
indiana top stories
life sciences
national blog main
new york blog main
new york top stories
slgt2 inhibitor
type 1 diabetes
type 2 diabetes
What
approval
bid
boehringer
diabetes
1
×
drug
eli
expand
fallen
fda
ingelheim
lilly
1
×
marketed
medicine’s
patients
rejects
short
type
Language
unset
Current search:
lilly
×
diabetes
×
@xconomy.com
4 years ago
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes
